Oncoprev™

Oncoprev™ for the safe, effective treatment of cancer. Oncoprev™ is a highly specific human monoclonal antibody that has been shown in human tumor xenografts to safely and effectively treat cancer by selectively targeting diseased, cancerous tissue while leaving normal tissue unharmed.

Oncoprev™ is in the IND application stage and is prepared to proceed to human clinical trials. Oncoprev is being developed as a monoclonal antibody based therapy that specifically targets cancerous cells and has shown to keep healthy cells in tact in all pre-clinical testing.

Oncorprev™ product development stage

Click the above image to open a larger version in a new window.

Oncoprev™ Technology (opens new page).